Quantcast

Latest Multiple drug resistance Stories

2014-06-19 08:28:10

Carbapenem Resistance Consortium Includes AstraZeneca, Cepheid, Cubist, and GSK SUNNYVALE, Calif., June 19, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced a new collaboration with AstraZeneca, Cubist Pharmaceuticals, Inc., and GSK intended to promote transformational change in infectious disease therapy by developing a rapid diagnostic test that can target multi-drug resistant pathogens and support the appropriate use of antibiotics. Targeting bacterial infections with the right...

2014-06-18 23:07:41

According to a new report from BCC Research, the global market for systemic antibiotics is expected to grow to $41.2 billion by 2018 with a compound annual growth rate (CAGR) of 0.8% between 2013 through 2018. Asian countries account for the fastest-growing market with a five-year CAGR of 1.2% due to the increasing aging population, increasing GDP rate and increasing awareness about healthcare. Wellesley, MA (PRWEB) June 18, 2014 BCC Research (http://www.bccresearch.com) reveals in its...

2014-06-16 08:27:47

On-demand molecular test detects and differentiates the genes encoding the most prevalent carbapenemases: KPC, NDM, VIM, OXA-48 and IMP-1 SUNNYVALE, Calif., June 16, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced the release of Xpert(®) Carba-R, an on-demand molecular test for rapid and accurate detection of carbapenemase-producing Gram-negative bacteria, to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on...

2014-05-15 12:36:52

Carbapenems Are Increasingly Being Deployed as Frontline Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., May 15, 2014 /PRNewswire/ -- Decision Resources Group finds that the majority of surveyed hospital-based infectious disease and critical/intensive care specialists in the EU5 (France, Germany, Italy, Spain and the United Kingdom) reported increases in infection rates due to key drug-resistant Gram-negative pathogens (GNPs) over the past two years. Further,...

2014-05-15 08:33:57

- Test Quickly Determines Colonization Risk of Multi-drug Resistant Microbes with Greater Accuracy than Currently Available Options - GAITHERSBURG, Md., May 15, 2014 /PRNewswire/ -- OpGen, Inc., a Gaithersburg based molecular diagnostics company, announced today that it has launched a new molecular-based test that can quickly and reliably identify patients at risk for harboring serious disease-causing microbes that can resist even the strongest antibiotics. The Acuitas(TM) MDRO Gene...

2014-04-23 12:30:07

Emerging Therapies Active Against Multidrug-Resistant Pathogens Will Be Preferred Over Generic Carbapenems, According to Findings from Decision Resources Group BURLINGTON, Mass., April 23, 2014 /PRNewswire/ -- Decision Resources Group finds that two emerging therapies in late-stage clinical development--AstraZeneca/Forest Laboratories' ceftazidime-avibactam and Tetraphase's eravacycline--will replace carbapenems as preferred therapies for treatment of gram-negative infections (GNIs) due to...

Kitchens A Source Of Multi-Drug Resistant Bacteria
2014-04-09 05:02:05

April Flowers for redOrbit.com - Your Universe Online From professional chef to housewife, every cook knows that handling raw poultry leaves your hands, tools and surfaces covered in drug-resistant bacteria such as E. coli. These bacteria produce extended-spectrum beta-lactamases (ESBLs), which are enzymes that make the bacteria resistant to many commonly used antibiotics. A new study from the University Hospital in Basel, Switzerland, examined household and hospital kitchens to...

2014-02-26 12:26:25

LONDON, Feb. 26, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: PharmaFocus: Market Access Strategies for Antibiotics Targeting Multidrug-Resistant Gram-Negative Bacteria PharmaFocus: Market Access Strategies for Antibiotics Targeting Multidrug-Resistant Gram-Negative Bacteria Summary Since their discovery almost a century ago, antibiotics have revolutionized the global healthcare industry by ushering in an era of significantly reduced morbidity...

2014-01-27 23:02:49

Research led by St. Jude Children’s Research Hospital scientists has produced new versions of an old antibiotic that are active against difficult-to-treat tuberculosis; offers new strategy for overcoming drug resistance Memphis, TN (PRWEB) January 27, 2014 St. Jude Children’s Research Hospital scientists have discovered a promising new class of antibiotics that could aid efforts to overcome drug-resistance in tuberculosis (TB), a global killer. The drugs increased survival of mice...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.